4.4 Article

White matter hyperintensities and changes in white matter integrity in patients with Alzheimer's disease

期刊

NEURORADIOLOGY
卷 53, 期 5, 页码 373-381

出版社

SPRINGER
DOI: 10.1007/s00234-010-0806-2

关键词

Magnetic resonance imaging; White matter hyperintensity; Diffusion tensor; Alzheimer's disease; White matter

资金

  1. NIH [R21AG027335]
  2. Emory Alzheimer's Disease Research Center (NIH-NIA) [P50 AG025688]

向作者/读者索取更多资源

White matter hyperintensities (WMHs) are a risk factor for Alzheimer's disease (AD). This study investigated the relationship between WMHs and white matter changes in AD using diffusion tensor imaging (DTI) and the sensitivity of each DTI index in distinguishing AD with WMHs. Forty-four subjects with WMHs were included. Subjects were classified into three groups based on the Scheltens rating scale: 15 AD patients with mild WMHs, 12 AD patients with severe WMHs, and 17 controls with mild WMHs. Fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity (D-R), and axial diffusivity (D-A) were analyzed using the region of interest and tract-based spatial statistics methods. Sensitivity and specificity of DTI indices in distinguishing AD groups from the controls were evaluated. AD patients with mild WMHs exhibited differences from control subjects in most DTI indices in the medial temporal and frontal areas; however, differences in DTI indices from AD patients with mild WMHs and AD patients with severe WMHs were found in the parietal and occipital areas. FA and D-R were more sensitive measurements than MD and D-A in differentiating AD patients from controls, while MD was a more sensitive measurement in distinguishing AD patients with severe WMHs from those with mild WMHs. WMHs may contribute to the white matter changes in AD brains, specifically in temporal and frontal areas. Changes in parietal and occipital lobes may be related to the severity of WMHs. D-R may serve as an imaging marker of myelin deficits associated with AD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment

Allan I. Levey, Deqiang Qiu, Liping Zhao, William T. Hu, Duc M. Duong, Lenora Higginbotham, Eric B. Dammer, Nicholas T. Seyfried, Thomas S. Wingo, Chadwick M. Hales, Malu Gamez Tansey, David S. Goldstein, Anees Abrol, Vince D. Calhoun, Felicia C. Goldstein, Ihab Hajjar, Anne M. Fagan, Doug Galasko, Steven D. Edland, John Hanfelt, James J. Lah, David Weinshenker

Summary: The study demonstrated that atomoxetine, a clinically approved noradrenaline reuptake inhibitor, improved multiple Alzheimer's disease biomarkers in individuals with mild cognitive impairment. Treatment with atomoxetine significantly reduced CSF levels of Tau and pTau, normalized CSF protein biomarker panels linked to synaptic function, brain metabolism, and glial immunity, and increased brain activity and metabolism in key temporal lobe circuits.
Article Geriatrics & Gerontology

The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias

Alexis A. Bender, Rebecca L. McIntosh, Sean Sudduth, Michaela Harris, Kathy Tuckey, John C. Morgan, Joanna M. Jungerman, Abby Cox, Miranda A. Moore, Bryshia Ingram, Ellyn Pier, Theodore M. Johnson, David W. Loring, Kenneth Hepburn, Laura Medders, Allan Levey, James J. Lah, Chadwick M. Hales

Summary: GMN is an innovative care model aimed at improving access to accurate and timely diagnosis for patients with memory loss. It may help enhance the quality of life for patients and families through preventive and early care.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2022)

Article Neurosciences

Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level

Erik C. B. Johnson, E. Kathleen Carter, Eric B. Dammer, Duc M. Duong, Ekaterina S. Gerasimov, Yue Liu, Jiaqi Liu, Ranjita Betarbet, Lingyan Ping, Luming Yin, Geidy E. Serrano, Thomas G. Beach, Junmin Peng, Philip L. De Jager, Vahram Haroutunian, Bin Zhang, Chris Gaiteri, David A. Bennett, Marla Gearing, Thomas S. Wingo, Aliza P. Wingo, James J. Lah, Allan I. Levey, Nicholas T. Seyfried

Summary: This study analyzed the proteomes of over 1,000 brain tissues and identified new protein co-expression modules associated with Alzheimer's disease. These modules were highly conserved across cohorts and brain regions and revealed a proteopathic nature of the disease. The study also found disease-associated modules unique to the proteome, which could serve as potential therapeutic targets and biomarkers for Alzheimer's disease.

NATURE NEUROSCIENCE (2022)

Article Clinical Neurology

Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias

Lei Yu, Patricia A. Boyle, Aliza P. Wingo, Jingyun Yang, Tianhao Wang, Aron S. Buchman, Thomas S. Wingo, Nicholas T. Seyfried, Allan Levey, Philip L. De Jager, Julie A. Schneider, David A. Bennett

Summary: The cortical proteins implicated in Alzheimer's dementia were found to be more associated with non-AD neurodegenerative and cerebrovascular conditions rather than AD pathology. Some proteins were found to be pleiotropic and associated with both neurodegenerative and cerebrovascular pathologies.

NEUROLOGY (2022)

Article Psychiatry

Brain microRNAs are associated with variation in cognitive trajectory in advanced age

Aliza P. Wingo, Mengli Wang, Jiaqi Liu, Michael S. Breen, Hyun-Sik Yang, Beisha Tang, Julie A. Schneider, Nicholas T. Seyfried, James J. Lah, Allan Levey, David A. Bennett, Peng Jin, Philip L. De Jager, Thomas S. Wingo

Summary: This study identified miR-29a-3p and miR-132-3p as novel and independent contributors to cognitive trajectory in older adults. These microRNAs have a significant impact on cognitive performance and are not influenced by common neurodegenerative pathologies. Additionally, the findings provide a foundation for future studies to explore the mechanisms and interventions to enhance cognitive stability in advanced age.

TRANSLATIONAL PSYCHIATRY (2022)

Article Neurosciences

Frontal Metabolites and Alzheimer's Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment

Antoine Hone-Blanchet, Anastasia Bohsali, Lisa C. Krishnamurthy, Salman S. Shahid, Qixiang Lin, Liping Zhao, Aditya S. Bisht, Samantha E. John, David Loring, Felicia Goldstein, Allan Levey, James Lah, Deqiang Qiu, Bruce Crosson

Summary: The study revealed an association between frontal GABA+ levels and neurological aging, with GABA+ levels being reduced in MCI patients. Additionally, N-acetylaspartate relative to myo-inositol (tNAA/mI) predicted cognition in MCI patients only and was not related to CSF biomarkers.

JOURNAL OF ALZHEIMERS DISEASE (2022)

Article Geriatrics & Gerontology

Proteome-Wide Discovery of Cortical Proteins That May Provide Motor Resilience to Offset the Negative Effects of Pathologies in Older Adults

Aron S. Buchman, Lei Yu, Hans-Ulrich Klein, Andrea R. Zammit, Shahram Oveisgharan, Francine Grodstein, Shinya Tasaki, Allan Levey, Nicholas T. Seyfried, David A. Bennett

Summary: This study identified cortical proteins that may provide motor resilience in older adults. Five proteins were associated with progressive parkinsonism, suggesting their potential as therapeutic targets for maintaining motor function despite untreatable brain pathologies.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Biochemistry & Molecular Biology

Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorder

Thomas S. Wingo, Ekaterina S. Gerasimov, Yue Liu, Duc M. Duong, Selina M. Vattathil, Adriana Lori, Jake Gockley, Michael S. Breen, Adam X. Maihofer, Caroline M. Nievergelt, Karestan C. Koenen, Daniel F. Levey, Joel Gelernter, Murray B. Stein, Kerry J. Ressler, David A. Bennett, Allan Levey, Nicholas T. Seyfried, Aliza P. Wingo

Summary: This study identified 11 genes that contribute to the pathogenesis of PTSD by regulating brain protein abundance. Seven of these genes were replicated in further studies and four also showed association with PTSD at the brain mRNA level. These findings provide promising targets for mechanistic and therapeutic studies for PTSD.

MOLECULAR PSYCHIATRY (2022)

Article Multidisciplinary Sciences

Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain

Sruti Rayaprolu, Sara Bitarafan, Juliet Santiago, Ranjita Betarbet, Sydney Sunna, Lihong Cheng, Hailian Xiao, Ruth S. Nelson, Prateek Kumar, Pritha Bagchi, Duc M. Duong, Annie M. Goettemoeller, Viktor Janos Olah, Matt Rowan, Allan Levey, Levi B. Wood, Nicholas T. Seyfried, Srikant Rangaraju

Summary: By using cell type-specific protein labeling, we can better study the proteomic differences between neurons and astrocytes, and identify potential factors related to neurological diseases.

NATURE COMMUNICATIONS (2022)

Article Chemistry, Multidisciplinary

Ectopic Lymphoid Follicle Formation and Human Seasonal Influenza Vaccination Responses Recapitulated in an Organ-on-a-Chip

Girija Goyal, Pranav Prabhala, Gautam Mahajan, Bruce Bausk, Tal Gilboa, Liangxia Xie, Yunhao Zhai, Roey Lazarovits, Adam Mansour, Min Sun Kim, Aditya Patil, Danielle Curran, Jaclyn M. Long, Sanjay Sharma, Abidemi Junaid, Limor Cohen, Thomas C. Ferrante, Oren Levy, Rachelle Prantil-Baun, David R. Walt, Donald E. Ingber

Summary: In this study, researchers successfully cultured human ectopic lymphoid follicles with similar characteristics to lymphoid follicles in a microfluidic chip. These follicles showed improved immune responses to vaccines and can serve as an alternative to non-human primates for preclinical evaluation.

ADVANCED SCIENCE (2022)

Article Clinical Neurology

Alzheimer's disease genetic burden is associated with mid-life depression among persons with normal cognition

Thomas S. Wingo, Ekaterina S. Gerasimov, Se Min Canon, James J. Lah, Allan Levey, Aliza P. Wingo

Summary: The study found that depression manifesting after age 50 is associated with a genetic predisposition to Alzheimer's disease (AD), suggesting that genetic predisposition may be a factor contributing to the pathogenesis of mid-life depression. Further study is needed to investigate whether there is a shared genetic basis between mid-life depression and AD.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

The landscape of metabolic brain alterations in Alzheimer's disease

Richa Batra, Matthias Arnold, Maria A. Woerheide, Mariet Allen, Xue Wang, Colette Blach, Allan Levey, Nicholas T. Seyfried, Nilufer Ertekin-Taner, David A. Bennett, Gabi Kastenmuller, Rima F. Kaddurah-Daouk, Jan Krumsiek

Summary: This study provides a comprehensive investigation and description of AD-associated metabolic changes, laying the foundation for future mechanistic research.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

LDL cholesterol is associated with higher AD neuropathology burden independent of APOE

Aliza P. Wingo, Selina M. Vattathil, Jiaqi Liu, Wen Fan, David J. Cutler, Allan Levey, Julie A. Schneider, David A. Bennett, Thomas S. Wingo

Summary: This study found that LDL-C is associated with various neuropathological manifestations of AD independent of APOE, suggesting that LDL-C may be a modifiable risk factor for AD.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Multidisciplinary Sciences

Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer's Disease

Caroline M. Watson, Eric B. Dammer, Lingyan Ping, Duc M. Duong, Erica Modeste, E. Kathleen Carter, Erik C. B. Johnson, Allan I. Levey, James J. Lah, Blaine R. Roberts, Nicholas T. Seyfried

Summary: Alzheimer's disease (AD) is the most common form of dementia, and CSF beta-amyloid, total Tau, and phosphorylated Tau (pTau) are sensitive and specific biomarkers for diagnosis. However, these biomarkers do not capture the complex changes in AD brain beyond amyloid and Tau pathologies. This study used SRM-MS with isotopically labeled standards to quantify CSF protein biomarkers, identifying proteins that could distinguish AD stages and cognitive impairment.

SCIENTIFIC DATA (2023)

Article Multidisciplinary Sciences

Automated analysis of facial emotions in subjects with cognitive impairment

Zifan Jiang, Salman Seyedi, Rafi U. Haque, Alvince L. Pongos, Kayci L. Vickers, Cecelia M. Manzanares, James J. Lah, Allan I. Levey, Gari D. Clifford

Summary: This study utilized a computer vision-based deep learning model to analyze facial emotions expressed by individuals with cognitive impairment. The findings show that cognitive impairment is associated with differences in facial emotion expression, which can be used as an effective tool for screening cognitive impairment.

PLOS ONE (2022)

暂无数据